Bristol-Myers Squibb Research and Development , P.O. Box 4000, Princeton, New Jersey 08543, United States.
J Med Chem. 2016 Mar 24;59(6):2820-40. doi: 10.1021/acs.jmedchem.6b00089. Epub 2016 Mar 10.
Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1-5) and evokes a variety of cellular responses through their stimulation. The interaction of S1P with the S1P receptors plays a fundamental physiological role in a number of processes including vascular development and stabilization, lymphocyte migration, and proliferation. Agonism of S1P1, in particular, has been shown to play a significant role in lymphocyte trafficking from the thymus and secondary lymphoid organs, resulting in immunosuppression. This article will detail the discovery and SAR of a potent and selective series of isoxazole based full agonists of S1P1. Isoxazole 6d demonstrated impressive efficacy when administered orally in a rat model of arthritis and in a mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
鞘氨醇 1-磷酸(S1P)是鞘氨醇 1-磷酸受体(S1P1-5)的内源性配体,通过刺激它们引发多种细胞反应。S1P 与 S1P 受体的相互作用在包括血管发育和稳定、淋巴细胞迁移和增殖在内的许多过程中发挥着基本的生理作用。特别是 S1P1 的激动作用已被证明在淋巴细胞从胸腺和次级淋巴器官的迁移中发挥重要作用,导致免疫抑制。本文将详细介绍一系列基于异恶唑的强效和选择性 S1P1 完全激动剂的发现和 SAR。异恶唑 6d 在关节炎大鼠模型和多发性硬化症的实验性自身免疫性脑脊髓炎(EAE)小鼠模型中口服给药时表现出令人印象深刻的疗效。